RNASEH2A and invasive breast carcinoma: Further analyses of RNASEH expression levels throughout different stages of lung squamous adenocarcinoma, breast invasive carcinoma, and bladder urothelial carcinoma again highlighted specific upregulation of RNASEH2A from normal tissues to early stages and more advanced stages of these cancers.